Android app on Google Play

RBC Capital Initiates Coverage on Drug Manufacturer Stocks AGN & ENDP

September 17, 2010 9:10 AM EDT Send to a Friend
Get Alerts AGN Hot Sheet
Price: $170.20 +0.97%

Rating Summary:
    19 Buy, 10 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 15 | Down: 16 | New: 67
Trade AGN Now!
Join SI Premium – FREE
RBC Capital initiates coverage on Allergan (NYSE: AGN) with an Outperform rating. PT $77.

RBC initiates coverage on Endo Pharmaceuticals (Nasdaq: ENDP) with a Sector Perform rating. PT $30.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

RBC Capital

Add Your Comment